Global Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2025

Global Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Parkinson's Disease (PD) Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Product
1.4.2 Dopamine Agonist
1.4.3 Monoamine Oxidase Inhibitors
1.4.4 Acetylcholinesterase Inhibitors
1.4.5 Glutamate Inhibitors
1.5 Market by End User
1.5.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Family
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Parkinson's Disease (PD) Drugs Market Size
2.1.1 Global Parkinson's Disease (PD) Drugs Revenue 2014-2025
2.1.2 Global Parkinson's Disease (PD) Drugs Sales 2014-2025
2.2 Parkinson's Disease (PD) Drugs Growth Rate by Regions
2.2.1 Global Parkinson's Disease (PD) Drugs Sales by Regions
2.2.2 Global Parkinson's Disease (PD) Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Parkinson's Disease (PD) Drugs Sales by Manufacturers
3.1.1 Parkinson's Disease (PD) Drugs Sales by Manufacturers
3.1.2 Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers
3.1.3 Global Parkinson's Disease (PD) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Parkinson's Disease (PD) Drugs Revenue by Manufacturers
3.2.1 Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Parkinson's Disease (PD) Drugs Price by Manufacturers
3.4 Parkinson's Disease (PD) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Parkinson's Disease (PD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parkinson's Disease (PD) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Parkinson's Disease (PD) Drugs Sales by Product
4.2 Global Parkinson's Disease (PD) Drugs Revenue by Product
4.3 Parkinson's Disease (PD) Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Parkinson's Disease (PD) Drugs Breakdown Data by End User
6 North America
6.1 North America Parkinson's Disease (PD) Drugs by Countries
6.1.1 North America Parkinson's Disease (PD) Drugs Sales by Countries
6.1.2 North America Parkinson's Disease (PD) Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Parkinson's Disease (PD) Drugs by Product
6.3 North America Parkinson's Disease (PD) Drugs by End User
7 Europe
7.1 Europe Parkinson's Disease (PD) Drugs by Countries
7.1.1 Europe Parkinson's Disease (PD) Drugs Sales by Countries
7.1.2 Europe Parkinson's Disease (PD) Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Parkinson's Disease (PD) Drugs by Product
7.3 Europe Parkinson's Disease (PD) Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Parkinson's Disease (PD) Drugs by Countries
8.1.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Countries
8.1.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Parkinson's Disease (PD) Drugs by Product
8.3 Asia Pacific Parkinson's Disease (PD) Drugs by End User
9 Central & South America
9.1 Central & South America Parkinson's Disease (PD) Drugs by Countries
9.1.1 Central & South America Parkinson's Disease (PD) Drugs Sales by Countries
9.1.2 Central & South America Parkinson's Disease (PD) Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Parkinson's Disease (PD) Drugs by Product
9.3 Central & South America Parkinson's Disease (PD) Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Parkinson's Disease (PD) Drugs by Countries
10.1.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Countries
10.1.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Parkinson's Disease (PD) Drugs by Product
10.3 Middle East and Africa Parkinson's Disease (PD) Drugs by End User
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Company Business Overview
11.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
11.1.5 Boehringer Ingelheim Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered
11.3.5 Novartis Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Company Business Overview
11.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Details
11.5.2 Company Business Overview
11.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered
11.5.5 AbbVie Recent Development
11.6 Abital Pharma
11.6.1 Abital Pharma Company Details
11.6.2 Company Business Overview
11.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered
11.6.5 Abital Pharma Recent Development
11.7 Addex Therapeutics
11.7.1 Addex Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered
11.7.5 Addex Therapeutics Recent Development
11.8 Biogen
11.8.1 Biogen Company Details
11.8.2 Company Business Overview
11.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered
11.8.5 Biogen Recent Development
11.9 Eisai
11.9.1 Eisai Company Details
11.9.2 Company Business Overview
11.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered
11.9.5 Eisai Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Company Business Overview
11.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered
11.10.5 Eli Lilly Recent Development
11.11 F. Hoffmann-La Roche
11.12 H. Lundbeck
11.13 Impax Laboratories
11.14 Kyowa Hakko Kirin
11.15 Otsuka Pharmaceutical
11.16 Pfizer
12 Future Forecast
12.1 Parkinson's Disease (PD) Drugs Market Forecast by Regions
12.1.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Regions 2019-2025
12.2 Parkinson's Disease (PD) Drugs Market Forecast by Product
12.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Product 2019-2025
12.3 Parkinson's Disease (PD) Drugs Market Forecast by End User
12.4 North America Parkinson's Disease (PD) Drugs Forecast
12.5 Europe Parkinson's Disease (PD) Drugs Forecast
12.6 Asia Pacific Parkinson's Disease (PD) Drugs Forecast
12.7 Central & South America Parkinson's Disease (PD) Drugs Forecast
12.8 Middle East and Africa Parkinson's Disease (PD) Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parkinson's Disease (PD) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Parkinson's Disease (PD) Drugs Product Picture
Table Parkinson's Disease (PD) Drugs Market Segments
Table Key Manufacturers Parkinson's Disease (PD) Drugs Covered
Table Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Product 2014-2025
Figure Dopamine Agonist Product Picture
Table Major Manufacturers of Dopamine Agonist
Figure Monoamine Oxidase Inhibitors Product Picture
Table Major Manufacturers of Monoamine Oxidase Inhibitors
Figure Acetylcholinesterase Inhibitors Product Picture
Table Major Manufacturers of Acetylcholinesterase Inhibitors
Figure Glutamate Inhibitors Product Picture
Table Major Manufacturers of Glutamate Inhibitors
Table Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Hospital
Figure Family
Figure Parkinson's Disease (PD) Drugs Report Years Considered
Figure Global Parkinson's Disease (PD) Drugs Market Size 2014-2025 (Million US$)
Figure Global Parkinson's Disease (PD) Drugs Sales 2014-2025 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Parkinson's Disease (PD) Drugs Sales by Regions 2014-2019 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions 2014-2019
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions
Table Global Parkinson's Disease (PD) Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions
Table Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2014-2019)
Figure Parkinson's Disease (PD) Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Parkinson's Disease (PD) Drugs Price (2014-2019) (USD/Pcs)
Table Parkinson's Disease (PD) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Parkinson's Disease (PD) Drugs Sales by Product (2014-2019) (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Product (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Product (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Product in 2018
Table Global Parkinson's Disease (PD) Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Parkinson's Disease (PD) Drugs Revenue Share by Product (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Product (2014-2019)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Product in 2018
Table Parkinson's Disease (PD) Drugs Price by Product 2014-2019 (USD/Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales by End User (2014-2019) (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Share by End User (2014-2019)
Figure Global Sales Parkinson's Disease (PD) Drugs Market Share by End User (2014-2019)
Figure Global Sales Parkinson's Disease (PD) Drugs Market Share by End User in 2018
Figure North America Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Parkinson's Disease (PD) Drugs Sales by Countries (2014-2019) (K Pcs)
Table North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries
Table North America Parkinson's Disease (PD) Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries
Figure United States Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Parkinson's Disease (PD) Drugs Sales by Product (2014-2019) (K Pcs)
Table North America Parkinson's Disease (PD) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Parkinson's Disease (PD) Drugs Market Share by Product
Table North America Parkinson's Disease (PD) Drugs Sales by End User (2014-2019) (K Pcs)
Table North America Parkinson's Disease (PD) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Parkinson's Disease (PD) Drugs Market Share by End User
Figure Europe Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Parkinson's Disease (PD) Drugs Sales by Countries (2014-2019) (K Pcs)
Table Europe Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Parkinson's Disease (PD) Drugs Sales Market Share by Countries
Table Europe Parkinson's Disease (PD) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Countries
Figure Germany Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure France Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Parkinson's Disease (PD) Drugs Sales by Product (2014-2019) (K Pcs)
Table Europe Parkinson's Disease (PD) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Parkinson's Disease (PD) Drugs Market Share by Product
Table Europe Parkinson's Disease (PD) Drugs Sales by End User (2014-2019) (K Pcs)
Table Europe Parkinson's Disease (PD) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Parkinson's Disease (PD) Drugs Market Share by End User
Figure Asia Pacific Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Parkinson's Disease (PD) Drugs Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Countries
Table Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Countries
Figure China Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure China Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure India Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Parkinson's Disease (PD) Drugs Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Parkinson's Disease (PD) Drugs Market Share by Product
Table Asia Pacific Parkinson's Disease (PD) Drugs Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Parkinson's Disease (PD) Drugs Market Share by End User
Figure Central & South America Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Parkinson's Disease (PD) Drugs Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Parkinson's Disease (PD) Drugs Sales Market Share by Countries
Table Central & South America Parkinson's Disease (PD) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries
Figure Brazil Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Parkinson's Disease (PD) Drugs Sales by Product (2014-2019) (K Pcs)
Table Central & South America Parkinson's Disease (PD) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Parkinson's Disease (PD) Drugs Market Share by Product
Table Central & South America Parkinson's Disease (PD) Drugs Sales by End User (2014-2019) (K Pcs)
Table Central & South America Parkinson's Disease (PD) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Parkinson's Disease (PD) Drugs Market Share by End User
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Countries
Table Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Countries
Figure GCC Countries Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Parkinson's Disease (PD) Drugs Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Parkinson's Disease (PD) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Parkinson's Disease (PD) Drugs Market Share by Product
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Parkinson's Disease (PD) Drugs Market Share by End User
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table AbbVie Company Details
Table AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Abital Pharma Company Details
Table Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abital Pharma Recent Development
Table Addex Therapeutics Company Details
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addex Therapeutics Recent Development
Table Biogen Company Details
Table Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen Recent Development
Table Eisai Company Details
Table Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table F. Hoffmann-La Roche Company Details
Table H. Lundbeck Company Details
Table Impax Laboratories Company Details
Table Kyowa Hakko Kirin Company Details
Table Otsuka Pharmaceutical Company Details
Table Pfizer Company Details
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Parkinson's Disease (PD) Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Parkinson's Disease (PD) Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Parkinson's Disease (PD) Drugs Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Parkinson's Disease (PD) Drugs Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Parkinson's Disease (PD) Drugs Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Parkinson's Disease (PD) Drugs Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Parkinson's Disease (PD) Drugs Value Chain
Table Parkinson's Disease (PD) Drugs Customers List
Table Parkinson's Disease (PD) Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs